Qiagen NV | QIA - Market Capitalization

Stock Price
28.44
Daily Change
0.32 1.14%
Monthly
-19.56%
Yearly
-25.69%
Q2 Forecast
27.51

Qiagen NV reported $6.21B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
argenx SE USD 39.98B 4.4B May/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
IQVIA Holdings USD 32.02B 3.39B May/2026
Moderna USD 20.15B 8.53B Mar/2026
Qiagen NV USD 6.43B 1.85B May/2026
Revvity USD 11.4B 1.46B May/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 20.65B 4.92B May/2026
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025